2024 · pending · WO2025240482A1

Treatment of CSPG4 Related Diseases and Disorders

Gregory McInnes

Compositions comprising oligonucleotides (siRNA or ASO) that target CSPG4 for treating conditions associated with CSPG4.

RNA Therapeutics